Cryptic Pathways and Implications for Novel Drug Discovery
Author:
- Kozo OchiKOKozo Ochi
- 1 January 2017
- book chapter
- Published by Elsevier
- p. 189-203
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Elicitation of secondary metabolism in actinomycetesBiotechnology Advances, 2015
- Genome mining of rare actinomycetes and cryptic pathway awakeningProcess Biochemistry, 2015
- Rifampicin-resistance, rpoB polymorphism and RNA polymerase genetic engineeringJournal of Biotechnology, 2015
- Metabolite induction via microorganism co-culture: A potential way to enhance chemical diversity for drug discoveryBiotechnology Advances, 2014
- Exploitation of the Streptomyces coelicolor A3(2) genome sequence for discovery of new natural products and biosynthetic pathwaysJournal of Industrial Microbiology and Biotechnology, 2014
- Chemical Perturbation of Secondary Metabolism Demonstrates Important Links to Primary MetabolismChemistry & Biology, 2012
- Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganismsCurrent Opinion in Chemical Biology, 2011
- Strain improvement in actinomycetes in the postgenomic eraJournal of Industrial Microbiology and Biotechnology, 2011
- Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clustersJournal of Industrial Microbiology and Biotechnology, 2010
- Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)Nature, 2002